Introduction to Fibroscan – ICST

Introduction to Fibroscan

Tutorial presented by Dr Andrew Yeoman, National Liver Clinical Lead and Consultant Hepatologist, Aneurin Bevan University Health Board

Fibroscan is transient elastography, which measures the stiffness of the liver. When scar tissue is present in the liver, the liver is more stiff than normal. The normal range for Fibroscan is less than 7kPa, a measurement between 8 and 12kPa is suggestive of increased liver stiffness, anything more than 12 could be compatible with advanced liver fibrosis, and more than 15 is highly suggestive of cirrhosis. Attached in the resources below are the normal Fibroscan ranges for different liver diseases.

A typical patient who would be referred for a Fibroscan is if they have a high fibrosis risk on the reflex Fibrosis Risk Assessment.

Refer with caution if:

  • The patient has a BMI greater than 40kg/m2
  • The patient has a pacemaker
  • The patient is unable to lie flat with a hand behind their head

Introduction to Fibroscan

Tutorial presented by Dr Andrew Yeoman, National Liver Clinical Lead and Consultant Hepatologist, Aneurin Bevan University Health Board

Fibroscan is transient elastography, which measures the stiffness of the liver. When scar tissue is present in the liver, the liver is more stiff than normal. The normal range for Fibroscan is less than 7kPa, a measurement between 8 and 12kPa is suggestive of increased liver stiffness, anything more than 12 could be compatible with advanced liver fibrosis, and more than 15 is highly suggestive of cirrhosis. Attached in the resources below are the normal Fibroscan ranges for different liver diseases.

A typical patient who would be referred for a Fibroscan is if they have a high fibrosis risk on the reflex Fibrosis Risk Assessment.

Refer with caution if:

  • The patient has a BMI greater than 40kg/m2
  • The patient has a pacemaker
  • The patient is unable to lie flat with a hand behind their head
Mark as Understood

More like this

Further Investigations

What does a “positive” fibrosis risk assessment mean?

Significant fibrosis, what does it mean for the patient?

© Institute of Clinical Science and Technology (ICST) 2020 Support: support@icst.org.uk